Indication
Metastatic gastric cancer
Metastatic gastric cancer is an advanced, stage IV malignancy arising from the epithelial lining of the stomach—predominantly classified as gastric adenocarcinoma—that has disseminated beyond locoregional lymph nodes and tissues. Read more about Metastatic gastric cancer
44 drugs 32 manufacturers
Drugs that treat it
Common Metastatic gastric cancer therapies.
ADRIAMYCIN (doxorubicin HCl)
DOXORUBICIN HCL
MITOMYCIN
MITOMYCIN
MITOMYCIN
MITOMYCIN
MITOMYCIN
MITOMYCIN
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMetastatic gastric cancer is an advanced, stage IV malignancy arising from the epithelial lining of the stomach—predominantly classified as gastric adenocarcinoma—that has disseminated beyond locoregional lymph nodes and tissues.
It affects the digestive system, most commonly in older adults, and spreads via lymphatic channels, the bloodstream, or direct transcoelomic shedding.
Defining pathophysiologic features include secondary neoplastic colonization of distant sites—frequently involving the peritoneum, liver, lungs, distant lymph nodes, and ovaries—which clinically manifests with epigastric pain, early satiety, progressive cachexia, gastrointestinal bleeding, malignant ascites, and distant organ dysfunction.
- cancer.gov
Metastatic gastric cancer is an advanced, stage IV malignancy arising from the epithelial lining of the stomach—predominantly classified as gastric adenocarcinoma—that has disseminated beyond locoregional lymph nodes and tissues Defining pathophysiologic features include secondary neoplastic colonization of distant sites—frequently involving the peritoneum, liver, lungs, distant lymph nodes, and ovaries—which clinically manifests with epigastric pain, early satiety, progressive cachexia, gastroi...
- nih.gov
Metastatic gastric cancer is an advanced, stage IV malignancy arising from the epithelial lining of the stomach—predominantly classified as gastric adenocarcinoma—that has disseminated beyond locoregional lymph nodes and tissues
- cancer.gov
It affects the digestive system, most commonly in older adults, and spreads via lymphatic channels, the bloodstream, or direct transcoelomic shedding
- nih.gov
It affects the digestive system, most commonly in older adults, and spreads via lymphatic channels, the bloodstream, or direct transcoelomic shedding Defining pathophysiologic features include secondary neoplastic colonization of distant sites—frequently involving the peritoneum, liver, lungs, distant lymph nodes, and ovaries—which clinically manifests with epigastric pain, early satiety, progressive cachexia, gastrointestinal bleeding, malignant ascites, and distant organ dysfunction
- cancer.gov
Defining pathophysiologic features include secondary neoplastic colonization of distant sites—frequently involving the peritoneum, liver, lungs, distant lymph nodes, and ovaries—which clinically manifests with epigastric pain, early satiety, progressive cachexia, gastrointestinal bleeding, malignant ascites, and distant organ dysfunction
- nih.gov
Defining pathophysiologic features include secondary neoplastic colonization of distant sites—frequently involving the peritoneum, liver, lungs, distant lymph nodes, and ovaries—which clinically manifests with epigastric pain, early satiety, progressive cachexia, gastrointestinal bleeding, malignant ascites, and distant organ dysfunction
Personalize your experience
Follow Metastatic gastric cancer and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.